{"gene":"CDKN1C","run_date":"2026-04-28T17:28:52","timeline":{"discoveries":[{"year":1999,"finding":"p57(KIP2) and p21(CIP1) redundantly control skeletal muscle differentiation at the myogenin step; mice lacking both fail to form myotubes, displaying increased myoblast proliferation and apoptosis, and endoreplication in residual myotubes, indicating cell-cycle exit is required for myogenin function and muscle-specific gene expression.","method":"Double-knockout mouse genetics, histology, BrdU incorporation, gene expression analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — clean double-KO with specific phenotypic readout and pathway placement, replicated in vivo","pmids":["9925645"],"is_preprint":false},{"year":2008,"finding":"p57/KIP2 triggers endoreduplication and differentiation of trophoblast stem cells into trophoblast giant cells by inhibiting CDK1 activity; p57 is required specifically for CDK1 inhibition to initiate endoreduplication, while p21 concurrently suppresses CHK1 to prevent apoptosis.","method":"CDK1 inhibitor (RO3306) treatment, p57/p21 mutant TS cell analysis, CDK kinase assays, immunofluorescence","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1–2 — chemical inhibition plus genetic mutants with defined mechanistic readout in a single study","pmids":["18981479"],"is_preprint":false},{"year":2000,"finding":"p57(Kip2) physically interacts with MyoD via its N-terminal alpha-helix domain (located between the CDK and cyclin binding sites) and the basic HLH domain of MyoD, stabilizing MyoD by increasing its half-life independently of CDK inhibitory activity.","method":"Co-immunoprecipitation of overexpressed and endogenous proteins, transactivation assays, site-directed mutagenesis, protein half-life measurement","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — reciprocal Co-IP on endogenous proteins, mutagenesis identifying interacting domains, multiple functional assays","pmids":["10764802"],"is_preprint":false},{"year":2012,"finding":"Gain-of-function missense mutations in the PCNA-binding domain of CDKN1C cause IMAGe syndrome; IMAGe-associated mutations result in loss of PCNA binding; expression of mutant CDKN1C in Drosophila caused severe eye growth defects compared to wild-type, suggesting a gain-of-function mechanism.","method":"Exome sequencing, Sanger sequencing, identity-by-descent analysis, Drosophila targeted expression assay, Co-IP for PCNA binding","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 1–2 — human genetics plus functional in vivo Drosophila assay with multiple orthogonal methods","pmids":["22634751"],"is_preprint":false},{"year":2013,"finding":"IMAGe-associated mutations in the PCNA-binding domain of CDKN1C dramatically increase protein stability via impaired proteasomal degradation, representing a gain-of-function mechanism; wild-type CDKN1C is normally degraded via the proteasome pathway.","method":"Cycloheximide chase, proteasome inhibitor (MG132) treatment, Western blot, Co-IP for PCNA binding","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1–2 — reconstitution with multiple mutations, cycloheximide chase and proteasome inhibitor controls","pmids":["24098681"],"is_preprint":false},{"year":2015,"finding":"IMAGe-associated mutations in the PCNA-binding domain of CDKN1C increase protein stability and prevent cell cycle progression into S phase; mutant CDKN1C inhibits cell proliferation more strongly than wild-type or BWS-mutant CDKN1C.","method":"Flow cytometry, cell proliferation assays, protein stability measurements, overexpression of wild-type and mutant CDKN1C","journal":"Cell division","confidence":"Medium","confidence_rationale":"Tier 2 — single lab, multiple orthogonal cell-based methods","pmids":["25861374"],"is_preprint":false},{"year":2012,"finding":"p57(Kip2) is phosphorylated at T143 by the p38 stress-activated protein kinase (SAPK), which enhances p57 association with and inhibition of Cdk2, resulting in cell-cycle delay and cell survival upon osmotic stress, oxidative stress, and ionomycin treatment.","method":"In vitro kinase assay, co-IP, genetic inactivation of p38 and p57, cell viability assays, stress-response assays","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — in vitro phosphorylation assay with mutagenesis, co-IP, genetic validation","pmids":["22569127"],"is_preprint":false},{"year":2009,"finding":"CDKN1C is a direct epigenetic target of the histone methyltransferase EZH2; EZH2-mediated H3K27me3 at the CDKN1C locus represses its expression in breast cancer cells, and this can be reversed by EZH2 inhibition synergized with HDAC inhibitors.","method":"ChIP for H3K27me3, EZH2 inhibition, HDAC inhibitor treatment, quantitative RT-PCR, Western blot","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — ChIP with pharmacological interventions in multiple cell systems","pmids":["19340297"],"is_preprint":false},{"year":2010,"finding":"CDKN1C negatively regulates RNA polymerase II CTD phosphorylation in an E2F1-dependent manner; CDKN1C is recruited to E2F1-regulated promoters, interacts with CDK7 and CDK9, and blocks their ability to phosphorylate the RNA Pol II CTD in vitro; E2F1 and CDKN1C form stable complexes mediated by two E2F1 domains.","method":"ChIP, co-IP, GST pull-down in vitro kinase assay, RNAi, adenoviral overexpression, Western blot for phospho-CTD","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro kinase assay, ChIP, and reciprocal Co-IP with mutagenesis in single study","pmids":["20106982"],"is_preprint":false},{"year":2004,"finding":"PTHrP's proliferative actions in chondrocytes are mediated at least in part through suppression of p57 expression; genetic ablation of p57 partially rescues the PTHrP-null bone phenotype, and PTHrP/PTH decreases p57 mRNA and protein levels in chondrocytes.","method":"Double-knockout mouse genetics (p57/PTHrP-null), metatarsal organ culture, PTH treatment, immunohistochemistry, in situ hybridization","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis in vivo plus organ culture with defined molecular readouts","pmids":["15124025"],"is_preprint":false},{"year":2006,"finding":"p57 is a direct transcriptional target repressed by Notch effector Hes1; inactivation of Hes1 upregulates p57 in pancreatic progenitors leading to cell cycle arrest and precocious differentiation; p57/Hes1 double-null embryos show expansion of progenitor populations due to absence of apoptosis.","method":"Genetic double-knockout mouse, immunohistochemistry, in situ hybridization, BrdU labeling, promoter analysis","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis (double-KO), direct Hes1 target validation, defined cellular phenotype","pmids":["16899237"],"is_preprint":false},{"year":2013,"finding":"p57 is required for neural stem cell (NSC) quiescence in the adult hippocampus; p57 deletion initially increases neurogenesis but leads to NSC exhaustion and impaired neurogenesis in aged mice; reduction of p57 in NSCs contributes to abrogation of quiescence by extrinsic neurogenic stimuli such as running.","method":"Conditional p57 knockout in NSCs, BrdU/Ki67 labeling, behavioral stimulation (running), immunofluorescence","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with defined cellular phenotype and functional consequence","pmids":["23481253"],"is_preprint":false},{"year":2006,"finding":"p57(Kip2) levels increase over time in proliferating oligodendrocyte precursor cells (OPCs) and regulate how many times an OPC can divide before differentiating, functioning as an intracellular timer; all daughters of an OPC clone express similar p57 levels.","method":"In vitro clonal analysis, immunostaining, overexpression and knockdown in OPCs","journal":"The Journal of neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — defined cellular phenotype with quantitative clone analysis and mechanistic follow-up","pmids":["17553990"],"is_preprint":false},{"year":2006,"finding":"p57 and p27 are required for neuronal migration in the developing mouse neocortex; knockdown of p57 by RNAi causes significant delay in cortical plate migration without affecting neuronal differentiation.","method":"In utero electroporation, RNAi knockdown, immunohistochemistry, cortical plate analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — in vivo RNAi with defined cellular phenotype (migration defect)","pmids":["17092932"],"is_preprint":false},{"year":2018,"finding":"Subcellular localization of p57(Kip2) is dynamic in muscle stem cells; p57 is initially cytoplasmic in activated/proliferating myoblasts and undergoes progressive nuclear translocation to cause growth arrest during differentiation; Cdkn1c-deficient myoblasts show differentiation defects and increased proliferation.","method":"Mouse molecular genetics (Cdkn1c KO), immunofluorescence, subcellular fractionation, primary myoblast isolation and culture","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 — direct localization experiment with functional consequence, KO phenotype, multiple methods","pmids":["30284969"],"is_preprint":false},{"year":2017,"finding":"p57KIP2 mediates an S phase-dependent cell fate switch in early erythroid progenitors; p57KIP2-mediated slowing of replication forks is required for progenitor self-renewal, and down-regulation of p57KIP2 at differentiation onset causes a global increase in replication fork speed and shorter S phase.","method":"In vivo erythroid progenitor analysis, DNA fiber assay, flow cytometry, p57KIP2 KO mouse","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 1–2 — DNA fiber assay (mechanistic), in vivo KO, multiple orthogonal methods","pmids":["28560351"],"is_preprint":false},{"year":2013,"finding":"ARX directly represses Cdkn1c transcription; loss of Arx in cortical progenitors causes CDKN1C overexpression and reduced IPC proliferation; ARX was identified as a direct transcriptional regulator of CDKN1C by transcriptional profiling and direct binding studies.","method":"Conditional KO mouse, transcriptional profiling, ChIP, in situ hybridization, immunohistochemistry","journal":"Cerebral cortex","confidence":"Medium","confidence_rationale":"Tier 2 — KO phenotype with ChIP validation of direct transcriptional regulation","pmids":["23968833"],"is_preprint":false},{"year":2019,"finding":"The lncRNA Kcnq1ot1 promotes H3K27me3 accumulation at an intragenic MyoD-binding region of p57Kip2, suppressing its maternal allele expression during muscle differentiation; upon differentiation, MyoD binding to this region coincides with loss of EZH2/H3K27me3 and p57 de-repression.","method":"ChIP, RNA immunoprecipitation, Chromatin Oligo-affinity Precipitation, siRNA knockdown, allele-specific expression analysis","journal":"Epigenetics & chromatin","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP and RIP with allele-specific analysis, multiple orthogonal methods","pmids":["30651140"],"is_preprint":false},{"year":2012,"finding":"CSN6 (COP9 signalosome subunit 6) associates with p57(Kip2) and Skp2 (an SCF E3 ligase component), facilitating Skp2-mediated ubiquitination and proteasomal degradation of p57; CSN6 overexpression destabilizes p57 and promotes cell cycle progression.","method":"Co-IP, ubiquitination assay, CSN6 overexpression/knockdown, Western blot, cell proliferation assays","journal":"Cell cycle","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP, ubiquitination assay, loss-of-function rescue, single lab","pmids":["23187808"],"is_preprint":false},{"year":2013,"finding":"Akt phosphorylates p57(Kip2) at Ser282 or Thr310, causes cytoplasmic localization, accelerates protein turnover via ubiquitination, and thereby promotes HER2-mediated cell proliferation and tumorigenicity.","method":"Co-IP, phosphorylation mapping, ubiquitination assay, subcellular fractionation, cell proliferation/transformation assays","journal":"Cell cycle","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP plus phosphorylation site identification, ubiquitination assay, functional rescue","pmids":["23421998"],"is_preprint":false},{"year":2022,"finding":"FBXO22, a component of the SCF E3 ubiquitin ligase complex, physically interacts with p57Kip2 and mediates its ubiquitination and proteasomal degradation, promoting G1/S phase progression and cervical cancer cell proliferation.","method":"Co-IP, ubiquitination assay, protein half-life measurement, overexpression/knockdown, xenograft","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP plus direct ubiquitination assay with functional validation","pmids":["36127346"],"is_preprint":false},{"year":2021,"finding":"RNF26 degrades p57(CDKN1C) to regulate cell cycle progression in bladder cancer; RNF26 expression is transcriptionally promoted by FOXM1 via the MuvB complex, forming a FOXM1/RNF26/p57 axis that modulates cell cycle and bladder cancer progression.","method":"Co-IP, Western blot, cell cycle analysis, gain- and loss-of-function experiments, ChIP","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP and ChIP with functional cell cycle readout, pathway defined","pmids":["34650035"],"is_preprint":false},{"year":2005,"finding":"Lsh, a SNF2 chromatin remodeling protein, directly associates with the 5' differentially methylated region (DMR) at the Cdkn1c promoter and controls CpG methylation at this locus to maintain paternal allele silencing; loss of Lsh causes reactivation of the silent paternal Cdkn1c allele.","method":"Chromatin immunoprecipitation (ChIP), allele-specific expression analysis, bisulfite sequencing, Lsh-deficient embryos","journal":"Development","confidence":"High","confidence_rationale":"Tier 2 — direct ChIP evidence, allele-specific expression, bisulfite sequencing in KO model","pmids":["15647320"],"is_preprint":false},{"year":2018,"finding":"Targeted demethylation of the imprinting control region 2 (ICR2) using an ICR2-TET1 fusion protein represses p57 expression and promotes proliferation of human islet β cells while maintaining glucose-sensing functionality.","method":"TALE-TET1 epigenetic editing, Ki-67 staining, p57 Western blot, human islet transplantation in diabetic mice","journal":"The Journal of clinical investigation","confidence":"Medium","confidence_rationale":"Tier 2 — direct epigenetic editing with functional consequence in human primary cells and in vivo transplant model","pmids":["30352048"],"is_preprint":false},{"year":2022,"finding":"p57Kip2 is a molecular gatekeeper of the reserve stem cell state of gastric chief cells; p57 is constitutively expressed in homeostatic chief cells, rapidly diminishes after injury to allow robust proliferation, and its overexpression impairs injury response and locks cells in a reserve stem cell state.","method":"scRNA-seq, doxycycline-induced lineage tracing, in vivo constitutive p57 expression, corpus organoids, p57 overexpression","journal":"Cell stem cell","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal in vivo and in vitro genetic approaches with defined cellular phenotype","pmids":["35523142"],"is_preprint":false},{"year":2019,"finding":"p57KIP2 expression is strongly induced by increased cell density in normal trophoblast stem cells and mediates contact inhibition; loss of p57KIP2 expression in androgenetic (CHM-derived) trophoblast stem cells causes resistance to contact inhibition and enhanced proliferation at confluence.","method":"Knockout and overexpression studies in human trophoblast stem cells, cell density assays","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — KO and OE with specific phenotypic readout in human cells","pmids":["31792181"],"is_preprint":false},{"year":2011,"finding":"p57 downregulation in hepatocellular carcinoma cells increases CDK4/cyclin D1 and CDK2/cyclin E complex activities and accelerates invasion via controlling LIMK1 activity; stable p57 knockdown increases xenograft growth.","method":"Stable shRNA knockdown, CDK kinase immunocomplex assays, invasion assay, LIMK1 activity measurement, xenograft","journal":"Carcinogenesis","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function with CDK kinase assays and defined pathway placement (LIMK1)","pmids":["22002319"],"is_preprint":false},{"year":2019,"finding":"In Drosophila, the cyclin-dependent kinase inhibitor Dacapo (ortholog of p57KIP2) determines whether neural stem cells enter G0 or G2 quiescence; the dorsal patterning factor Msh binds directly to the Dap locus and induces Dap expression in dorsal NSCs, resulting in G0 arrest.","method":"ChIP, Drosophila genetics (msh and dap mutants), immunostaining, cell cycle staging","journal":"Developmental cell","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP plus genetic epistasis in Drosophila ortholog system","pmids":["30905769"],"is_preprint":false},{"year":2017,"finding":"The bHLH transcription factor E47 directly activates Cdkn1c expression by binding to a distal enhancer at the CDKN1C gene locus; E47 overexpression upregulates p57(KIP2) and disturbs layer-specific neurogenesis in vivo.","method":"ChIP-Seq, RNA-Seq, in utero electroporation, ChIP validation","journal":"Development","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP-Seq with in vivo functional validation","pmids":["28939666"],"is_preprint":false},{"year":2002,"finding":"p73β, but not p53, activates transcription of CDKN1C (p57KIP2) and KvLQT1; p73 can regulate imprinted genes through mechanisms not shared by p53.","method":"Transient transfection reporter assays, Northern blot, comparison of p53 and p73 activity","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 3 — reporter assay and expression analysis, single lab","pmids":["11891335"],"is_preprint":false},{"year":2023,"finding":"SKP2 E3-ubiquitin ligase directly targets p57Kip2 for degradation in fusion-negative rhabdomyosarcoma, preventing myogenic differentiation; MYOD drives SKP2 overexpression via binding to an intronic enhancer, forming a MYOD-SKP2-p57 axis.","method":"Co-IP, ubiquitination assay, ChIP, RNA-seq, SKP2 knockdown/overexpression, in vivo xenograft","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1–2 — direct ubiquitination assay, ChIP, and in vivo validation with multiple orthogonal methods","pmids":["38102140"],"is_preprint":false},{"year":2009,"finding":"SMARCB1 restoration transcriptionally activates CDKN1C in rhabdoid tumor cells through increased histone H3 and H4 acetylation at the CDKN1C promoter; CDKN1C expression induces cell cycle arrest and knockdown of CDKN1C increases proliferation.","method":"Inducible SMARCB1 expression, ChIP for histone acetylation, siRNA knockdown, flow cytometry","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP evidence with functional KD/rescue, single lab","pmids":["19221586"],"is_preprint":false},{"year":2019,"finding":"EZH2-mediated H3K27me3 at the CDKN1C promoter region is promoted by CDYL, which recruits EZH2 to silences CDKN1C transcription; EZH2 inhibition by GSK126 de-represses CDKN1C and decreases CDYL-induced chemoresistance in SCLC cells.","method":"ChIP-qPCR, Co-IP, GST pull-down, EMSA, bisulfite sequencing, gain- and loss-of-function experiments","journal":"Theranostics","confidence":"Medium","confidence_rationale":"Tier 2 — ChIP plus direct protein interaction assays, multiple methods","pmids":["31367252"],"is_preprint":false},{"year":2015,"finding":"Paternal allelic mutation at Kcnq1 reduces pancreatic β-cell mass by disrupting Kcnq1ot1 expression, which leads to increased Cdkn1c expression on the normally silenced maternal allele through altered histone modification at the Cdkn1c promoter in pancreatic islets.","method":"Kcnq1 KO mouse (allele-specific), ChIP for histone modifications, β-cell mass measurement, islet gene expression","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"Medium","confidence_rationale":"Tier 2 — allele-specific KO with ChIP mechanistic validation","pmids":["26100882"],"is_preprint":false}],"current_model":"CDKN1C (p57KIP2) is a maternally-expressed, imprinted CDK inhibitor that restrains cell proliferation by binding and inhibiting cyclin/CDK complexes (especially CDK1 and CDK2); its stability is regulated by proteasomal degradation facilitated by multiple E3 ligases (SKP2, FBXO22, RNF26) and phosphorylation by Akt and p38-SAPK; it controls transcription by recruiting to E2F1-regulated promoters and inhibiting RNA Pol II CTD kinases (CDK7/CDK9); it interacts directly with MyoD to stabilize it during myogenesis; its subcellular localization (cytoplasmic vs. nuclear) is dynamically regulated and determines its growth-arrest function; it acts as a key regulator of stem cell quiescence, trophoblast giant cell differentiation (via CDK1 inhibition), oligodendrocyte precursor timing, erythroid cell fate (via replication fork speed control), and gastric chief cell reserve state; and its expression is epigenetically silenced by EZH2-mediated H3K27me3 (recruited by lncRNAs such as Kcnq1ot1 and BLACAT1) and by Lsh-dependent DNA methylation."},"narrative":{"teleology":[{"year":1999,"claim":"Establishing that p57 is not merely redundant with p21 but cooperatively essential for cell-cycle exit during skeletal muscle differentiation resolved whether CIP/KIP family members have overlapping developmental roles.","evidence":"p57/p21 double-knockout mice failed to form myotubes, with persistent proliferation and apoptosis in myoblasts","pmids":["9925645"],"confidence":"High","gaps":["Relative individual contributions of p57 versus p21 to each step of myogenesis not separated","Downstream CDK targets in myoblast exit not identified"]},{"year":2000,"claim":"Discovery of a CDK-inhibition-independent function—direct physical stabilization of MyoD—revealed that p57 acts as a multifunctional scaffold linking cell-cycle arrest to myogenic transcription factor activity.","evidence":"Co-IP of endogenous proteins, domain mapping, and half-life measurements showed p57 N-terminal helix binds MyoD bHLH domain and increases MyoD stability","pmids":["10764802"],"confidence":"High","gaps":["Whether p57–MyoD interaction is required in vivo for myogenesis not shown genetically","Mechanism by which p57 prevents MyoD degradation (e.g., which E3 ligase is blocked) not identified"]},{"year":2004,"claim":"Genetic epistasis between p57 and PTHrP demonstrated that p57 is a critical downstream effector of growth plate signaling, placing it at the nexus of endocrine/paracrine regulation of chondrocyte proliferation.","evidence":"p57 deletion partially rescued PTHrP-null bone phenotype; PTH/PTHrP treatment reduced p57 mRNA and protein in chondrocytes","pmids":["15124025"],"confidence":"High","gaps":["Transcription factors mediating PTHrP-dependent p57 repression not identified","Whether p57 inhibits CDK4/6 or CDK2 in chondrocytes not resolved"]},{"year":2005,"claim":"Identification of Lsh-dependent DNA methylation at the Cdkn1c differentially methylated region established a direct chromatin-remodeling mechanism for paternal allele silencing of this imprinted locus.","evidence":"ChIP, bisulfite sequencing, and allele-specific expression in Lsh-deficient embryos showed Lsh binds the Cdkn1c DMR and maintains CpG methylation","pmids":["15647320"],"confidence":"High","gaps":["How Lsh is recruited specifically to the Cdkn1c DMR not determined","Relationship between Lsh-mediated methylation and Kcnq1ot1-mediated silencing not clarified"]},{"year":2006,"claim":"Two concurrent findings—Hes1-mediated transcriptional repression in pancreatic progenitors and timer function in oligodendrocyte precursors—established p57 as a broadly used intracellular timer converting developmental signals into cell-cycle exit decisions.","evidence":"Hes1/p57 double-KO mouse epistasis and promoter analysis; clonal OPC culture with quantitative p57 accumulation measurements","pmids":["16899237","17553990"],"confidence":"High","gaps":["Mechanism of progressive p57 protein accumulation in OPCs not defined","Whether Hes1 binds the p57 promoter directly in vivo confirmed only by promoter analysis"]},{"year":2006,"claim":"RNAi-mediated p57 knockdown caused cortical neuron migration defects independent of differentiation, revealing a CDK-inhibitor function in post-mitotic neuronal migration not previously appreciated.","evidence":"In utero electroporation of shRNA against p57 in mouse neocortex","pmids":["17092932"],"confidence":"Medium","gaps":["Direct CDK target mediating migration effect not identified","Single knockdown approach without genetic KO confirmation"]},{"year":2008,"claim":"Demonstrating that p57 specifically inhibits CDK1 to initiate endoreduplication in trophoblast stem cells defined the molecular selectivity of p57 for a particular CDK in a physiological context.","evidence":"CDK1-selective inhibitor phenocopied p57 in TS cells; p57 mutant TS cells failed to endoreduplicate; CDK kinase assays confirmed CDK1 targeting","pmids":["18981479"],"confidence":"High","gaps":["How p57 selectivity for CDK1 over CDK2 is achieved structurally not resolved","Whether other CIP/KIP members can compensate for CDK1 inhibition in vivo"]},{"year":2009,"claim":"Identification of EZH2-mediated H3K27me3 as a direct silencing mark at the CDKN1C locus linked Polycomb repression to p57 loss in cancer, establishing a targetable epigenetic axis.","evidence":"ChIP for H3K27me3 in breast cancer cells; pharmacological EZH2 and HDAC inhibition de-repressed CDKN1C","pmids":["19340297"],"confidence":"High","gaps":["Mechanism recruiting EZH2 specifically to CDKN1C in breast cancer cells not fully defined","Whether H3K27me3 removal is sufficient to restore full p57 function not tested"]},{"year":2010,"claim":"Discovering that p57 is recruited to E2F1-regulated promoters and directly inhibits CDK7/CDK9 phosphorylation of the RNA Pol II CTD expanded p57's role from a pure cell-cycle inhibitor to a transcriptional co-regulator.","evidence":"ChIP showed p57 at E2F1 target promoters; in vitro kinase assays demonstrated p57 blocks CDK7/CDK9 CTD phosphorylation; Co-IP mapped E2F1–p57 interaction domains","pmids":["20106982"],"confidence":"High","gaps":["Genome-wide scope of p57's transcriptional regulatory role not mapped","Whether CDK7 vs CDK9 inhibition has distinct transcriptional consequences not distinguished"]},{"year":2012,"claim":"Human genetic and functional studies established that gain-of-function PCNA-binding-domain mutations in CDKN1C cause IMAGe syndrome by dramatically increasing protein stability, linking the PCNA-dependent degradation pathway to a Mendelian growth restriction disorder.","evidence":"Exome sequencing of IMAGe families; Co-IP showing loss of PCNA binding; Drosophila expression assay; cycloheximide chase and proteasome inhibitor experiments","pmids":["22634751","24098681"],"confidence":"High","gaps":["Identity of the E3 ligase that ubiquitinates p57 via PCNA interaction not determined at this stage","Whether IMAGe mutations affect CDK-inhibitory activity in addition to stability not fully resolved"]},{"year":2012,"claim":"Identification of p38-SAPK phosphorylation at T143 as a signal that enhances p57–CDK2 binding revealed how stress signals are converted into cell-cycle delay through post-translational modification of a CKI.","evidence":"In vitro kinase assay, mutagenesis of T143, Co-IP showing enhanced CDK2 binding, genetic validation with p38/p57 inactivation","pmids":["22569127"],"confidence":"High","gaps":["Whether T143 phosphorylation also affects p57 interactions with CDK1 or other partners not tested","Phosphatase responsible for reversing this modification not identified"]},{"year":2012,"claim":"CSN6-facilitated SKP2-mediated ubiquitination established the first defined E3 ligase pathway for proteasomal p57 turnover, with subsequent studies confirming SKP2, FBXO22, and RNF26 as parallel degradation routes.","evidence":"Co-IP and ubiquitination assays for CSN6/SKP2/p57; later confirmed by FBXO22 (2022) and RNF26 (2021) ubiquitination assays with functional cell-cycle readouts","pmids":["23187808","36127346","34650035","38102140"],"confidence":"Medium","gaps":["Relative contributions of SKP2, FBXO22, and RNF26 in different tissues not compared","Degron motifs recognized by each E3 ligase not precisely mapped beyond PCNA-binding domain"]},{"year":2013,"claim":"Conditional knockout of p57 in adult hippocampal neural stem cells demonstrated that p57 is essential for maintaining quiescence and preventing stem cell exhaustion, generalizing p57's role as a quiescence gatekeeper beyond embryonic development.","evidence":"Conditional p57 KO in NSCs with BrdU/Ki67 tracing; initial neurogenesis burst followed by long-term NSC depletion","pmids":["23481253"],"confidence":"High","gaps":["Whether p57 enforces quiescence through CDK inhibition alone or also through transcriptional co-regulation in NSCs not resolved","Upstream signals that maintain p57 expression in quiescent NSCs not fully defined"]},{"year":2013,"claim":"Akt-mediated phosphorylation at Ser282/Thr310 was shown to drive cytoplasmic relocalization and accelerated ubiquitin-dependent degradation of p57, revealing how growth factor signaling inactivates p57 to promote proliferation.","evidence":"Phosphorylation mapping, subcellular fractionation, ubiquitination assays in HER2-overexpressing cells","pmids":["23421998"],"confidence":"Medium","gaps":["Whether Akt phosphorylation feeds into SKP2 or a distinct E3 ligase pathway not determined","In vivo relevance of Akt–p57 axis not validated genetically"]},{"year":2017,"claim":"DNA fiber assays revealed that p57 slows replication fork speed in erythroid progenitors and that its downregulation triggers a global fork speed increase coinciding with differentiation, establishing an unexpected S-phase-intrinsic role for a CKI in cell-fate decisions.","evidence":"DNA fiber assay in sorted erythroid progenitors from p57 KO and WT mice, flow cytometry for S-phase length","pmids":["28560351"],"confidence":"High","gaps":["Molecular mechanism by which p57 slows replication forks (direct fork association vs. CDK inhibition at forks) not resolved","Whether fork speed regulation is specific to erythroid cells or general"]},{"year":2018,"claim":"Dynamic cytoplasmic-to-nuclear translocation of p57 in muscle stem cells demonstrated that subcellular localization is a regulated switch controlling the timing of growth arrest and differentiation onset.","evidence":"Immunofluorescence and subcellular fractionation in primary myoblasts; Cdkn1c KO showed differentiation defects","pmids":["30284969"],"confidence":"High","gaps":["Kinase or signal controlling nuclear import timing not identified","Whether cytoplasmic p57 has active non-CDK functions in myoblasts not explored"]},{"year":2019,"claim":"The lncRNA Kcnq1ot1 was shown to recruit EZH2 to deposit H3K27me3 at an intragenic MyoD-binding region of p57, directly linking imprinting-associated lncRNA to the epigenetic silencing mechanism and its reversal during myogenic differentiation.","evidence":"ChIP, RNA immunoprecipitation, and chromatin oligo-affinity precipitation with allele-specific analysis in myoblasts","pmids":["30651140"],"confidence":"Medium","gaps":["Whether Kcnq1ot1 uses the same EZH2-recruitment mechanism in non-muscle tissues not tested","Structural basis for Kcnq1ot1–EZH2 interaction not characterized"]},{"year":2022,"claim":"Identification of p57 as a molecular gatekeeper of the reserve stem cell state in gastric chief cells extended its quiescence-maintenance role to adult tissue homeostasis and injury response, showing that rapid p57 loss is required for damage-induced regeneration.","evidence":"scRNA-seq, lineage tracing, in vivo constitutive p57 expression, and corpus organoid experiments","pmids":["35523142"],"confidence":"High","gaps":["Upstream signal that triggers rapid p57 downregulation upon gastric injury not identified","Whether p57 loss alone is sufficient for chief cell dedifferentiation or requires cooperating signals"]},{"year":null,"claim":"Key unresolved questions include: which E3 ligase mediates PCNA-dependent p57 degradation in the IMAGe syndrome context; how p57 mechanistically slows replication forks; what signals control the cytoplasmic-to-nuclear translocation switch; and whether p57's transcriptional co-regulatory function via CDK7/CDK9 inhibition is genome-wide or restricted to specific promoter classes.","evidence":"","pmids":[],"confidence":"Low","gaps":["PCNA-dependent E3 ligase identity unresolved","Structural basis for p57 at replication forks unknown","Nuclear import signal and its regulatory kinase/phosphatase not mapped","Genome-wide ChIP for p57 occupancy at promoters not performed"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,6,8,11,12,15,24,25,26]},{"term_id":"GO:0140096","term_label":"catalytic activity, acting on a protein","supporting_discovery_ids":[1,6,8,26]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[8,14]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[14,19]}],"pathway":[{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[0,1,5,6,15,18,19,20,21,25,26]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,1,9,10,11,12,13,14,24]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[8,17,22,31,32,33]},{"term_id":"R-HSA-4839726","term_label":"Chromatin organization","supporting_discovery_ids":[7,17,22,32,33]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[4,18,19,20,21,30]}],"complexes":[],"partners":["CDK1","CDK2","MYOD1","E2F1","SKP2","FBXO22","EZH2","CDK7"],"other_free_text":[]},"mechanistic_narrative":"CDKN1C (p57KIP2) is a maternally expressed, imprinted cyclin-dependent kinase inhibitor that enforces cell-cycle exit, quiescence, and differentiation across diverse stem and progenitor cell populations. It directly binds and inhibits cyclin–CDK complexes—particularly CDK1 to trigger trophoblast giant cell endoreduplication and CDK2 upon p38-mediated T143 phosphorylation during stress responses—and additionally inhibits RNA Pol II CTD kinases CDK7 and CDK9 at E2F1-regulated promoters, thereby coupling cell-cycle arrest to transcriptional reprogramming [PMID:18981479, PMID:22569127, PMID:20106982]. Its protein levels are tightly controlled by proteasomal degradation mediated by the E3 ligases SCF-SKP2, SCF-FBXO22, and RNF26, with Akt phosphorylation promoting cytoplasmic relocalization and turnover, while IMAGe syndrome–causing gain-of-function mutations in the PCNA-binding domain impair this degradation and cause growth restriction [PMID:22634751, PMID:24098681, PMID:36127346, PMID:34650035, PMID:23421998]. Epigenetic silencing of CDKN1C is maintained by EZH2-catalyzed H3K27me3 directed by the lncRNA Kcnq1ot1 and by Lsh-dependent DNA methylation at the imprinting control region, while chromatin remodelers such as SMARCB1 and transcription factors including E47, Hes1, and ARX dynamically regulate its expression in tissue-specific contexts [PMID:19340297, PMID:30651140, PMID:15647320, PMID:19221586, PMID:16899237]."},"prefetch_data":{"uniprot":{"accession":"P49918","full_name":"Cyclin-dependent kinase inhibitor 1C","aliases":["Cyclin-dependent kinase inhibitor p57","p57Kip2"],"length_aa":316,"mass_kda":32.2,"function":"Potent tight-binding inhibitor of several G1 cyclin/CDK complexes (cyclin E-CDK2, cyclin D2-CDK4, and cyclin A-CDK2) and, to lesser extent, of the mitotic cyclin B-CDC2. Negative regulator of cell proliferation. May play a role in maintenance of the non-proliferative state throughout life","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P49918/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CDKN1C","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CDKN1C","total_profiled":1310},"omim":[{"mim_id":"618844","title":"L3MBTL HISTONE METHYL-LYSINE-BINDING PROTEIN 3; L3MBTL3","url":"https://www.omim.org/entry/618844"},{"mim_id":"618336","title":"INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI","url":"https://www.omim.org/entry/618336"},{"mim_id":"618178","title":"NEPHROTIC SYNDROME, TYPE 19; NPHS19","url":"https://www.omim.org/entry/618178"},{"mim_id":"614732","title":"INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, AND GENITAL ANOMALIES; IMAGE","url":"https://www.omim.org/entry/614732"},{"mim_id":"614041","title":"RB TRANSCRIPTIONAL COREPRESSOR 1; RB1","url":"https://www.omim.org/entry/614041"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Nuclear bodies","reliability":"Approved"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":191.6},{"tissue":"ovary","ntpm":188.1}],"url":"https://www.proteinatlas.org/search/CDKN1C"},"hgnc":{"alias_symbol":["P57","KIP2"],"prev_symbol":["BWCR","BWS"]},"alphafold":{"accession":"P49918","domains":[{"cath_id":"-","chopping":"79-116","consensus_level":"medium","plddt":72.7811,"start":79,"end":116},{"cath_id":"1.20.5","chopping":"36-70","consensus_level":"medium","plddt":94.8411,"start":36,"end":70}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P49918","model_url":"https://alphafold.ebi.ac.uk/files/AF-P49918-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P49918-F1-predicted_aligned_error_v6.png","plddt_mean":62.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CDKN1C","jax_strain_url":"https://www.jax.org/strain/search?query=CDKN1C"},"sequence":{"accession":"P49918","fasta_url":"https://rest.uniprot.org/uniprotkb/P49918.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P49918/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P49918"}},"corpus_meta":[{"pmid":"9925645","id":"PMC_9925645","title":"p21(CIP1) and p57(KIP2) control muscle differentiation at the myogenin step.","date":"1999","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/9925645","citation_count":348,"is_preprint":false},{"pmid":"20519948","id":"PMC_20519948","title":"Ubiquitylation and proteasomal degradation of the p21(Cip1), p27(Kip1) and p57(Kip2) CDK inhibitors.","date":"2010","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/20519948","citation_count":190,"is_preprint":false},{"pmid":"24224124","id":"PMC_24224124","title":"Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA.","date":"2013","source":"American journal of cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/24224124","citation_count":154,"is_preprint":false},{"pmid":"18981479","id":"PMC_18981479","title":"Differentiation of trophoblast stem cells into giant cells is triggered by p57/Kip2 inhibition of CDK1 activity.","date":"2008","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/18981479","citation_count":153,"is_preprint":false},{"pmid":"19340297","id":"PMC_19340297","title":"CDKN1C (p57) is a direct target of EZH2 and suppressed by multiple epigenetic mechanisms in breast cancer cells.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19340297","citation_count":142,"is_preprint":false},{"pmid":"10424811","id":"PMC_10424811","title":"Analysis of germline CDKN1C (p57KIP2) mutations in familial and sporadic Beckwith-Wiedemann syndrome (BWS) provides a novel genotype-phenotype correlation.","date":"1999","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10424811","citation_count":138,"is_preprint":false},{"pmid":"22634751","id":"PMC_22634751","title":"Mutations in the PCNA-binding domain of CDKN1C cause IMAGe syndrome.","date":"2012","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/22634751","citation_count":131,"is_preprint":false},{"pmid":"10601037","id":"PMC_10601037","title":"Oppositely imprinted genes p57(Kip2) and igf2 interact in a mouse model for Beckwith-Wiedemann syndrome.","date":"1999","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/10601037","citation_count":130,"is_preprint":false},{"pmid":"16899237","id":"PMC_16899237","title":"p57 and Hes1 coordinate cell cycle exit with self-renewal of pancreatic progenitors.","date":"2006","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/16899237","citation_count":130,"is_preprint":false},{"pmid":"11181570","id":"PMC_11181570","title":"Increased tumour risk for BWS patients correlates with aberrant H19 and not KCNQ1OT1 methylation: occurrence of KCNQ1OT1 hypomethylation in familial cases of BWS.","date":"2001","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11181570","citation_count":125,"is_preprint":false},{"pmid":"11044465","id":"PMC_11044465","title":"p57(Kip2) regulates the proper development of labyrinthine and spongiotrophoblasts.","date":"2000","source":"Molecular human reproduction","url":"https://pubmed.ncbi.nlm.nih.gov/11044465","citation_count":124,"is_preprint":false},{"pmid":"14627666","id":"PMC_14627666","title":"Silencing of CDKN1C (p57KIP2) is associated with hypomethylation at KvDMR1 in Beckwith-Wiedemann syndrome.","date":"2003","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14627666","citation_count":123,"is_preprint":false},{"pmid":"23481253","id":"PMC_23481253","title":"p57 controls adult neural stem cell quiescence and modulates the pace of lifelong neurogenesis.","date":"2013","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/23481253","citation_count":120,"is_preprint":false},{"pmid":"15888726","id":"PMC_15888726","title":"ZAC, LIT1 (KCNQ1OT1) and p57KIP2 (CDKN1C) are in an imprinted gene network that may play a role in Beckwith-Wiedemann syndrome.","date":"2005","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/15888726","citation_count":103,"is_preprint":false},{"pmid":"21447370","id":"PMC_21447370","title":"The hallmarks of CDKN1C (p57, KIP2) in cancer.","date":"2011","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/21447370","citation_count":91,"is_preprint":false},{"pmid":"10764802","id":"PMC_10764802","title":"Stabilization of MyoD by direct binding to p57(Kip2).","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10764802","citation_count":89,"is_preprint":false},{"pmid":"11891335","id":"PMC_11891335","title":"Induction of p57(KIP2) expression by p73beta.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/11891335","citation_count":85,"is_preprint":false},{"pmid":"15652708","id":"PMC_15652708","title":"Genomic imprinting of IGF2, p57(KIP2) and PEG1/MEST in a marsupial, the tammar wallaby.","date":"2005","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/15652708","citation_count":85,"is_preprint":false},{"pmid":"12514787","id":"PMC_12514787","title":"Immunohistochemical characterization of p57(KIP2) expression in early hydatidiform moles.","date":"2002","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/12514787","citation_count":79,"is_preprint":false},{"pmid":"11737597","id":"PMC_11737597","title":"Podocyte expression of the CDK-inhibitor p57 during development and disease.","date":"2001","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/11737597","citation_count":79,"is_preprint":false},{"pmid":"21278784","id":"PMC_21278784","title":"MicroRNA-221 inhibits CDKN1C/p57 expression in human colorectal carcinoma.","date":"2011","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/21278784","citation_count":78,"is_preprint":false},{"pmid":"17092932","id":"PMC_17092932","title":"The cyclin-dependent kinase inhibitors p57 and p27 regulate neuronal migration in the developing mouse neocortex.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17092932","citation_count":78,"is_preprint":false},{"pmid":"25262539","id":"PMC_25262539","title":"CDKN1C mutations: two sides of the same coin.","date":"2014","source":"Trends in molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25262539","citation_count":77,"is_preprint":false},{"pmid":"21729874","id":"PMC_21729874","title":"Fetal overgrowth in the Cdkn1c mouse model of Beckwith-Wiedemann syndrome.","date":"2011","source":"Disease models & mechanisms","url":"https://pubmed.ncbi.nlm.nih.gov/21729874","citation_count":77,"is_preprint":false},{"pmid":"21816904","id":"PMC_21816904","title":"p57(Kip2) and cancer: time for a critical appraisal.","date":"2011","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/21816904","citation_count":76,"is_preprint":false},{"pmid":"30256413","id":"PMC_30256413","title":"LncRNA SNHG17 promotes gastric cancer progression by epigenetically silencing of p15 and p57.","date":"2018","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/30256413","citation_count":75,"is_preprint":false},{"pmid":"19513094","id":"PMC_19513094","title":"Lessons from BWS twins: complex maternal and paternal hypomethylation and a common source of haematopoietic stem cells.","date":"2009","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/19513094","citation_count":73,"is_preprint":false},{"pmid":"2962637","id":"PMC_2962637","title":"Amino acid sequence of P-57, a neurospecific calmodulin-binding protein.","date":"1987","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2962637","citation_count":70,"is_preprint":false},{"pmid":"2948561","id":"PMC_2948561","title":"Physicochemical and hydrodynamic characterization of P-57, a neurospecific calmodulin binding protein.","date":"1986","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2948561","citation_count":67,"is_preprint":false},{"pmid":"15124025","id":"PMC_15124025","title":"The cyclin-dependent kinase inhibitor p57(Kip2) mediates proliferative actions of PTHrP in chondrocytes.","date":"2004","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/15124025","citation_count":65,"is_preprint":false},{"pmid":"11454518","id":"PMC_11454518","title":"Molecular analysis of CDKN1C and TP53 in sporadic adrenal tumors.","date":"2001","source":"European journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/11454518","citation_count":65,"is_preprint":false},{"pmid":"17553990","id":"PMC_17553990","title":"A crucial role for p57(Kip2) in the intracellular timer that controls oligodendrocyte differentiation.","date":"2007","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/17553990","citation_count":65,"is_preprint":false},{"pmid":"20503313","id":"PMC_20503313","title":"CDKN1C (p57(Kip2)) analysis in Beckwith-Wiedemann syndrome (BWS) patients: Genotype-phenotype correlations, novel mutations, and polymorphisms.","date":"2010","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/20503313","citation_count":61,"is_preprint":false},{"pmid":"15647320","id":"PMC_15647320","title":"Lsh controls silencing of the imprinted Cdkn1c gene.","date":"2005","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/15647320","citation_count":60,"is_preprint":false},{"pmid":"26077438","id":"PMC_26077438","title":"Mutations of the Imprinted CDKN1C Gene as a Cause of the Overgrowth Beckwith-Wiedemann Syndrome: Clinical Spectrum and Functional Characterization.","date":"2015","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/26077438","citation_count":60,"is_preprint":false},{"pmid":"12466290","id":"PMC_12466290","title":"Domain regulation of imprinting cluster in Kip2/Lit1 subdomain on mouse chromosome 7F4/F5: large-scale DNA methylation analysis reveals that DMR-Lit1 is a putative imprinting control region.","date":"2002","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/12466290","citation_count":60,"is_preprint":false},{"pmid":"15533713","id":"PMC_15533713","title":"Methylation at mouse Cdkn1c is acquired during postimplantation development and functions to maintain imprinted expression.","date":"2004","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/15533713","citation_count":59,"is_preprint":false},{"pmid":"23968833","id":"PMC_23968833","title":"ARX regulates cortical intermediate progenitor cell expansion and upper layer neuron formation through repression of Cdkn1c.","date":"2013","source":"Cerebral cortex (New York, N.Y. : 1991)","url":"https://pubmed.ncbi.nlm.nih.gov/23968833","citation_count":54,"is_preprint":false},{"pmid":"29614816","id":"PMC_29614816","title":"Genetic and Epigenetic Control of CDKN1C Expression: Importance in Cell Commitment and Differentiation, Tissue Homeostasis and Human Diseases.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29614816","citation_count":54,"is_preprint":false},{"pmid":"33117811","id":"PMC_33117811","title":"Functional Versatility of the CDK Inhibitor p57Kip2.","date":"2020","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/33117811","citation_count":53,"is_preprint":false},{"pmid":"26100882","id":"PMC_26100882","title":"Paternal allelic mutation at the Kcnq1 locus reduces pancreatic β-cell mass by epigenetic modification of Cdkn1c.","date":"2015","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/26100882","citation_count":53,"is_preprint":false},{"pmid":"15551363","id":"PMC_15551363","title":"Multiple mechanisms downregulate CDKN1C in human bladder cancer.","date":"2005","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/15551363","citation_count":53,"is_preprint":false},{"pmid":"30352048","id":"PMC_30352048","title":"Targeted demethylation at the CDKN1C/p57 locus induces human β cell replication.","date":"2018","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/30352048","citation_count":51,"is_preprint":false},{"pmid":"18325103","id":"PMC_18325103","title":"CDKN1C/p57kip2 is a candidate tumor suppressor gene in human breast cancer.","date":"2008","source":"BMC cancer","url":"https://pubmed.ncbi.nlm.nih.gov/18325103","citation_count":51,"is_preprint":false},{"pmid":"28560351","id":"PMC_28560351","title":"Global increase in replication fork speed during a p57KIP2-regulated erythroid cell fate switch.","date":"2017","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/28560351","citation_count":50,"is_preprint":false},{"pmid":"10944603","id":"PMC_10944603","title":"Decreased expression of p57(KIP2)mRNA in human bladder cancer.","date":"2000","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/10944603","citation_count":49,"is_preprint":false},{"pmid":"19221586","id":"PMC_19221586","title":"Imprinted CDKN1C is a tumor suppressor in rhabdoid tumor and activated by restoration of SMARCB1 and histone deacetylase inhibitors.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19221586","citation_count":49,"is_preprint":false},{"pmid":"22569127","id":"PMC_22569127","title":"The p57 CDKi integrates stress signals into cell-cycle progression to promote cell survival upon stress.","date":"2012","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/22569127","citation_count":49,"is_preprint":false},{"pmid":"25057881","id":"PMC_25057881","title":"A novel variant in CDKN1C is associated with intrauterine growth restriction, short stature, and early-adulthood-onset diabetes.","date":"2014","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/25057881","citation_count":47,"is_preprint":false},{"pmid":"11414765","id":"PMC_11414765","title":"Imprinting status of 11p15 genes in Beckwith-Wiedemann syndrome patients with CDKN1C mutations.","date":"2001","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/11414765","citation_count":46,"is_preprint":false},{"pmid":"16575194","id":"PMC_16575194","title":"Imprinting disruption of the CDKN1C/KCNQ1OT1 domain: the molecular mechanisms causing Beckwith-Wiedemann syndrome and cancer.","date":"2006","source":"Cytogenetic and genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16575194","citation_count":46,"is_preprint":false},{"pmid":"20428755","id":"PMC_20428755","title":"p57: A multifunctional protein in cancer (Review).","date":"2010","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/20428755","citation_count":45,"is_preprint":false},{"pmid":"16949913","id":"PMC_16949913","title":"Multiplex short tandem repeat DNA analysis confirms the accuracy of p57(KIP2) immunostaining in the diagnosis of complete hydatidiform mole.","date":"2006","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/16949913","citation_count":45,"is_preprint":false},{"pmid":"35523142","id":"PMC_35523142","title":"p57Kip2 imposes the reserve stem cell state of gastric chief cells.","date":"2022","source":"Cell stem cell","url":"https://pubmed.ncbi.nlm.nih.gov/35523142","citation_count":43,"is_preprint":false},{"pmid":"30284969","id":"PMC_30284969","title":"Cellular localization of the cell cycle inhibitor Cdkn1c controls growth arrest of adult skeletal muscle stem cells.","date":"2018","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/30284969","citation_count":42,"is_preprint":false},{"pmid":"28147266","id":"PMC_28147266","title":"Visualizing Changes in Cdkn1c Expression Links Early-Life Adversity to Imprint Mis-regulation in Adults.","date":"2017","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/28147266","citation_count":40,"is_preprint":false},{"pmid":"24986528","id":"PMC_24986528","title":"Relevance of genomic imprinting in intrauterine human growth expression of CDKN1C, H19, IGF2, KCNQ1 and PHLDA2 imprinted genes.","date":"2014","source":"Journal of assisted reproduction and genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24986528","citation_count":39,"is_preprint":false},{"pmid":"11677056","id":"PMC_11677056","title":"Dynamic temporal and spatial regulation of the cdk inhibitor p57(kip2) during embryo morphogenesis.","date":"2001","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/11677056","citation_count":39,"is_preprint":false},{"pmid":"18854861","id":"PMC_18854861","title":"Determination of KCNQ1OT1 and H19 methylation levels in BWS and SRS patients using methylation-sensitive high-resolution melting analysis.","date":"2008","source":"European journal of human genetics : EJHG","url":"https://pubmed.ncbi.nlm.nih.gov/18854861","citation_count":38,"is_preprint":false},{"pmid":"31367252","id":"PMC_31367252","title":"CDYL promotes the chemoresistance of small cell lung cancer by regulating H3K27 trimethylation at the CDKN1C promoter.","date":"2019","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/31367252","citation_count":38,"is_preprint":false},{"pmid":"25960208","id":"PMC_25960208","title":"miR-25 promotes glioma cell proliferation by targeting CDKN1C.","date":"2015","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/25960208","citation_count":36,"is_preprint":false},{"pmid":"23421998","id":"PMC_23421998","title":"CDK inhibitor p57 (Kip2) is downregulated by Akt during HER2-mediated tumorigenicity.","date":"2013","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/23421998","citation_count":36,"is_preprint":false},{"pmid":"19386358","id":"PMC_19386358","title":"CDKN1C mutations in HELLP/preeclamptic mothers of Beckwith-Wiedemann Syndrome (BWS) patients.","date":"2009","source":"Placenta","url":"https://pubmed.ncbi.nlm.nih.gov/19386358","citation_count":36,"is_preprint":false},{"pmid":"32308561","id":"PMC_32308561","title":"Long non-coding RNA GAS5 accelerates oxidative stress in melanoma cells by rescuing EZH2-mediated CDKN1C downregulation.","date":"2020","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/32308561","citation_count":36,"is_preprint":false},{"pmid":"33072570","id":"PMC_33072570","title":"LncRNA-BLACAT1 Facilitates Proliferation, Migration and Aerobic Glycolysis of Pancreatic Cancer Cells by Repressing CDKN1C via EZH2-Induced H3K27me3.","date":"2020","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33072570","citation_count":35,"is_preprint":false},{"pmid":"12176039","id":"PMC_12176039","title":"A pro-apoptotic effect of the CDK inhibitor p57(Kip2) on staurosporine-induced apoptosis in HeLa cells.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12176039","citation_count":35,"is_preprint":false},{"pmid":"24098681","id":"PMC_24098681","title":"Increased protein stability of CDKN1C causes a gain-of-function phenotype in patients with IMAGe syndrome.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24098681","citation_count":33,"is_preprint":false},{"pmid":"22002319","id":"PMC_22002319","title":"Downregulation of p57 accelerates the growth and invasion of hepatocellular carcinoma.","date":"2011","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/22002319","citation_count":33,"is_preprint":false},{"pmid":"31792181","id":"PMC_31792181","title":"Loss of p57KIP2 expression confers resistance to contact inhibition in human androgenetic trophoblast stem cells.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31792181","citation_count":32,"is_preprint":false},{"pmid":"25588980","id":"PMC_25588980","title":"Inhibition of MiR-199a-5p reduced cell proliferation in autosomal dominant polycystic kidney disease through targeting CDKN1C.","date":"2015","source":"Medical science monitor : international medical journal of experimental and clinical research","url":"https://pubmed.ncbi.nlm.nih.gov/25588980","citation_count":32,"is_preprint":false},{"pmid":"34650035","id":"PMC_34650035","title":"The FOXM1/RNF26/p57 axis regulates the cell cycle to promote the aggressiveness of bladder cancer.","date":"2021","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/34650035","citation_count":32,"is_preprint":false},{"pmid":"31924768","id":"PMC_31924768","title":"Imprinted Cdkn1c genomic locus cell-autonomously promotes cell survival in cerebral cortex development.","date":"2020","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31924768","citation_count":31,"is_preprint":false},{"pmid":"28939666","id":"PMC_28939666","title":"The E2A splice variant E47 regulates the differentiation of projection neurons via p57(KIP2) during cortical development.","date":"2017","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/28939666","citation_count":31,"is_preprint":false},{"pmid":"23187808","id":"PMC_23187808","title":"CDK inhibitor p57 (Kip2) is negatively regulated by COP9 signalosome subunit 6.","date":"2012","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/23187808","citation_count":30,"is_preprint":false},{"pmid":"36127346","id":"PMC_36127346","title":"Fbxo22 promotes cervical cancer progression via targeting p57Kip2 for ubiquitination and degradation.","date":"2022","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/36127346","citation_count":28,"is_preprint":false},{"pmid":"11042273","id":"PMC_11042273","title":"A potential role for p15(Ink4b) and p57(Kip2) in liver development.","date":"2000","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/11042273","citation_count":27,"is_preprint":false},{"pmid":"22076965","id":"PMC_22076965","title":"The multiple roles of the cyclin-dependent kinase inhibitory protein p57(KIP2) in cerebral cortical neurogenesis.","date":"2012","source":"Developmental neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/22076965","citation_count":27,"is_preprint":false},{"pmid":"15890200","id":"PMC_15890200","title":"The Ankrd2, Cdkn1c and calcyclin genes are under the control of MyoD during myogenic differentiation.","date":"2005","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15890200","citation_count":26,"is_preprint":false},{"pmid":"29511350","id":"PMC_29511350","title":"TBX3 promotes proliferation of papillary thyroid carcinoma cells through facilitating PRC2-mediated p57KIP2 repression.","date":"2018","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/29511350","citation_count":26,"is_preprint":false},{"pmid":"30651140","id":"PMC_30651140","title":"The long non-coding RNA Kcnq1ot1 controls maternal p57 expression in muscle cells by promoting H3K27me3 accumulation to an intragenic MyoD-binding region.","date":"2019","source":"Epigenetics & chromatin","url":"https://pubmed.ncbi.nlm.nih.gov/30651140","citation_count":25,"is_preprint":false},{"pmid":"30905769","id":"PMC_30905769","title":"Dorsal-Ventral Differences in Neural Stem Cell Quiescence Are Induced by p57KIP2/Dacapo.","date":"2019","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/30905769","citation_count":24,"is_preprint":false},{"pmid":"27200075","id":"PMC_27200075","title":"Epigenetic Characterization of CDKN1C in Placenta Samples from Non-syndromic Intrauterine Growth Restriction.","date":"2016","source":"Frontiers in genetics","url":"https://pubmed.ncbi.nlm.nih.gov/27200075","citation_count":24,"is_preprint":false},{"pmid":"7534105","id":"PMC_7534105","title":"A constitutional BWS-related t(11;16) chromosome translocation occurring in the same region of chromosome 16 implicated in Wilms' tumors.","date":"1995","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/7534105","citation_count":23,"is_preprint":false},{"pmid":"26491224","id":"PMC_26491224","title":"Cellular Response upon Stress: p57 Contribution to the Final Outcome.","date":"2015","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/26491224","citation_count":22,"is_preprint":false},{"pmid":"10708569","id":"PMC_10708569","title":"Possible involvement of the p57(Kip2) gene in bone metabolism.","date":"2000","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10708569","citation_count":22,"is_preprint":false},{"pmid":"23171462","id":"PMC_23171462","title":"The role of AHI1 and CDKN1C in cutaneous T-cell lymphoma progression.","date":"2012","source":"Experimental dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/23171462","citation_count":22,"is_preprint":false},{"pmid":"15234339","id":"PMC_15234339","title":"Searching for genomic variants in IGF2 and CDKN1C in Silver-Russell syndrome patients.","date":"2004","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/15234339","citation_count":22,"is_preprint":false},{"pmid":"26985855","id":"PMC_26985855","title":"CDKIs p18(INK4c) and p57(Kip2) are involved in quiescence of CML leukemic stem cells after treatment with TKI.","date":"2016","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/26985855","citation_count":21,"is_preprint":false},{"pmid":"12482580","id":"PMC_12482580","title":"Increased expression of vascular endothelial growth factor in placentas of p57(Kip2) null embryos.","date":"2002","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/12482580","citation_count":21,"is_preprint":false},{"pmid":"17196232","id":"PMC_17196232","title":"EGCG-targeted p57/KIP2 reduces tumorigenicity of oral carcinoma cells: role of c-Jun N-terminal kinase.","date":"2006","source":"Toxicology and applied pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17196232","citation_count":21,"is_preprint":false},{"pmid":"10545601","id":"PMC_10545601","title":"A human p57(KIP2) transgene is not activated by passage through the maternal mouse germline.","date":"1999","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10545601","citation_count":21,"is_preprint":false},{"pmid":"21767919","id":"PMC_21767919","title":"The usefulness of p57(KIP2) immunohistochemical staining and genotyping test in the diagnosis of the hydatidiform mole.","date":"2011","source":"Pathology, research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/21767919","citation_count":20,"is_preprint":false},{"pmid":"32679543","id":"PMC_32679543","title":"lncRNA STEAP3-AS1 Modulates Cell Cycle Progression via Affecting CDKN1C Expression through STEAP3 in Colon Cancer.","date":"2020","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/32679543","citation_count":20,"is_preprint":false},{"pmid":"20106982","id":"PMC_20106982","title":"CDKN1C negatively regulates RNA polymerase II C-terminal domain phosphorylation in an E2F1-dependent manner.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20106982","citation_count":20,"is_preprint":false},{"pmid":"28857482","id":"PMC_28857482","title":"Dopaminergic and behavioural changes in a loss-of-imprinting model of Cdkn1c.","date":"2017","source":"Genes, brain, and behavior","url":"https://pubmed.ncbi.nlm.nih.gov/28857482","citation_count":19,"is_preprint":false},{"pmid":"33792119","id":"PMC_33792119","title":"CDKN1C-mediated growth inhibition by an EZH1/2 dual inhibitor overcomes resistance of mantle cell lymphoma to ibrutinib.","date":"2021","source":"Cancer science","url":"https://pubmed.ncbi.nlm.nih.gov/33792119","citation_count":19,"is_preprint":false},{"pmid":"10862080","id":"PMC_10862080","title":"Analysis of CDKN1C in Beckwith Wiedemann syndrome.","date":"2000","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/10862080","citation_count":19,"is_preprint":false},{"pmid":"25861374","id":"PMC_25861374","title":"Mutations in the PCNA-binding site of CDKN1C inhibit cell proliferation by impairing the entry into S phase.","date":"2015","source":"Cell division","url":"https://pubmed.ncbi.nlm.nih.gov/25861374","citation_count":19,"is_preprint":false},{"pmid":"38102140","id":"PMC_38102140","title":"MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38102140","citation_count":18,"is_preprint":false},{"pmid":"31497289","id":"PMC_31497289","title":"Analysis of CDKN1C in fetal growth restriction and pregnancy loss.","date":"2019","source":"F1000Research","url":"https://pubmed.ncbi.nlm.nih.gov/31497289","citation_count":18,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":48017,"output_tokens":7362,"usd":0.127241},"stage2":{"model":"claude-opus-4-6","input_tokens":11132,"output_tokens":4644,"usd":0.25764},"total_usd":0.384881,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"p57(KIP2) and p21(CIP1) redundantly control skeletal muscle differentiation at the myogenin step; mice lacking both fail to form myotubes, displaying increased myoblast proliferation and apoptosis, and endoreplication in residual myotubes, indicating cell-cycle exit is required for myogenin function and muscle-specific gene expression.\",\n      \"method\": \"Double-knockout mouse genetics, histology, BrdU incorporation, gene expression analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean double-KO with specific phenotypic readout and pathway placement, replicated in vivo\",\n      \"pmids\": [\"9925645\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"p57/KIP2 triggers endoreduplication and differentiation of trophoblast stem cells into trophoblast giant cells by inhibiting CDK1 activity; p57 is required specifically for CDK1 inhibition to initiate endoreduplication, while p21 concurrently suppresses CHK1 to prevent apoptosis.\",\n      \"method\": \"CDK1 inhibitor (RO3306) treatment, p57/p21 mutant TS cell analysis, CDK kinase assays, immunofluorescence\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — chemical inhibition plus genetic mutants with defined mechanistic readout in a single study\",\n      \"pmids\": [\"18981479\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"p57(Kip2) physically interacts with MyoD via its N-terminal alpha-helix domain (located between the CDK and cyclin binding sites) and the basic HLH domain of MyoD, stabilizing MyoD by increasing its half-life independently of CDK inhibitory activity.\",\n      \"method\": \"Co-immunoprecipitation of overexpressed and endogenous proteins, transactivation assays, site-directed mutagenesis, protein half-life measurement\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reciprocal Co-IP on endogenous proteins, mutagenesis identifying interacting domains, multiple functional assays\",\n      \"pmids\": [\"10764802\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Gain-of-function missense mutations in the PCNA-binding domain of CDKN1C cause IMAGe syndrome; IMAGe-associated mutations result in loss of PCNA binding; expression of mutant CDKN1C in Drosophila caused severe eye growth defects compared to wild-type, suggesting a gain-of-function mechanism.\",\n      \"method\": \"Exome sequencing, Sanger sequencing, identity-by-descent analysis, Drosophila targeted expression assay, Co-IP for PCNA binding\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — human genetics plus functional in vivo Drosophila assay with multiple orthogonal methods\",\n      \"pmids\": [\"22634751\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"IMAGe-associated mutations in the PCNA-binding domain of CDKN1C dramatically increase protein stability via impaired proteasomal degradation, representing a gain-of-function mechanism; wild-type CDKN1C is normally degraded via the proteasome pathway.\",\n      \"method\": \"Cycloheximide chase, proteasome inhibitor (MG132) treatment, Western blot, Co-IP for PCNA binding\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reconstitution with multiple mutations, cycloheximide chase and proteasome inhibitor controls\",\n      \"pmids\": [\"24098681\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"IMAGe-associated mutations in the PCNA-binding domain of CDKN1C increase protein stability and prevent cell cycle progression into S phase; mutant CDKN1C inhibits cell proliferation more strongly than wild-type or BWS-mutant CDKN1C.\",\n      \"method\": \"Flow cytometry, cell proliferation assays, protein stability measurements, overexpression of wild-type and mutant CDKN1C\",\n      \"journal\": \"Cell division\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — single lab, multiple orthogonal cell-based methods\",\n      \"pmids\": [\"25861374\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"p57(Kip2) is phosphorylated at T143 by the p38 stress-activated protein kinase (SAPK), which enhances p57 association with and inhibition of Cdk2, resulting in cell-cycle delay and cell survival upon osmotic stress, oxidative stress, and ionomycin treatment.\",\n      \"method\": \"In vitro kinase assay, co-IP, genetic inactivation of p38 and p57, cell viability assays, stress-response assays\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro phosphorylation assay with mutagenesis, co-IP, genetic validation\",\n      \"pmids\": [\"22569127\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CDKN1C is a direct epigenetic target of the histone methyltransferase EZH2; EZH2-mediated H3K27me3 at the CDKN1C locus represses its expression in breast cancer cells, and this can be reversed by EZH2 inhibition synergized with HDAC inhibitors.\",\n      \"method\": \"ChIP for H3K27me3, EZH2 inhibition, HDAC inhibitor treatment, quantitative RT-PCR, Western blot\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — ChIP with pharmacological interventions in multiple cell systems\",\n      \"pmids\": [\"19340297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"CDKN1C negatively regulates RNA polymerase II CTD phosphorylation in an E2F1-dependent manner; CDKN1C is recruited to E2F1-regulated promoters, interacts with CDK7 and CDK9, and blocks their ability to phosphorylate the RNA Pol II CTD in vitro; E2F1 and CDKN1C form stable complexes mediated by two E2F1 domains.\",\n      \"method\": \"ChIP, co-IP, GST pull-down in vitro kinase assay, RNAi, adenoviral overexpression, Western blot for phospho-CTD\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro kinase assay, ChIP, and reciprocal Co-IP with mutagenesis in single study\",\n      \"pmids\": [\"20106982\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PTHrP's proliferative actions in chondrocytes are mediated at least in part through suppression of p57 expression; genetic ablation of p57 partially rescues the PTHrP-null bone phenotype, and PTHrP/PTH decreases p57 mRNA and protein levels in chondrocytes.\",\n      \"method\": \"Double-knockout mouse genetics (p57/PTHrP-null), metatarsal organ culture, PTH treatment, immunohistochemistry, in situ hybridization\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in vivo plus organ culture with defined molecular readouts\",\n      \"pmids\": [\"15124025\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"p57 is a direct transcriptional target repressed by Notch effector Hes1; inactivation of Hes1 upregulates p57 in pancreatic progenitors leading to cell cycle arrest and precocious differentiation; p57/Hes1 double-null embryos show expansion of progenitor populations due to absence of apoptosis.\",\n      \"method\": \"Genetic double-knockout mouse, immunohistochemistry, in situ hybridization, BrdU labeling, promoter analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis (double-KO), direct Hes1 target validation, defined cellular phenotype\",\n      \"pmids\": [\"16899237\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"p57 is required for neural stem cell (NSC) quiescence in the adult hippocampus; p57 deletion initially increases neurogenesis but leads to NSC exhaustion and impaired neurogenesis in aged mice; reduction of p57 in NSCs contributes to abrogation of quiescence by extrinsic neurogenic stimuli such as running.\",\n      \"method\": \"Conditional p57 knockout in NSCs, BrdU/Ki67 labeling, behavioral stimulation (running), immunofluorescence\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with defined cellular phenotype and functional consequence\",\n      \"pmids\": [\"23481253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"p57(Kip2) levels increase over time in proliferating oligodendrocyte precursor cells (OPCs) and regulate how many times an OPC can divide before differentiating, functioning as an intracellular timer; all daughters of an OPC clone express similar p57 levels.\",\n      \"method\": \"In vitro clonal analysis, immunostaining, overexpression and knockdown in OPCs\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — defined cellular phenotype with quantitative clone analysis and mechanistic follow-up\",\n      \"pmids\": [\"17553990\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"p57 and p27 are required for neuronal migration in the developing mouse neocortex; knockdown of p57 by RNAi causes significant delay in cortical plate migration without affecting neuronal differentiation.\",\n      \"method\": \"In utero electroporation, RNAi knockdown, immunohistochemistry, cortical plate analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo RNAi with defined cellular phenotype (migration defect)\",\n      \"pmids\": [\"17092932\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Subcellular localization of p57(Kip2) is dynamic in muscle stem cells; p57 is initially cytoplasmic in activated/proliferating myoblasts and undergoes progressive nuclear translocation to cause growth arrest during differentiation; Cdkn1c-deficient myoblasts show differentiation defects and increased proliferation.\",\n      \"method\": \"Mouse molecular genetics (Cdkn1c KO), immunofluorescence, subcellular fractionation, primary myoblast isolation and culture\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization experiment with functional consequence, KO phenotype, multiple methods\",\n      \"pmids\": [\"30284969\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"p57KIP2 mediates an S phase-dependent cell fate switch in early erythroid progenitors; p57KIP2-mediated slowing of replication forks is required for progenitor self-renewal, and down-regulation of p57KIP2 at differentiation onset causes a global increase in replication fork speed and shorter S phase.\",\n      \"method\": \"In vivo erythroid progenitor analysis, DNA fiber assay, flow cytometry, p57KIP2 KO mouse\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — DNA fiber assay (mechanistic), in vivo KO, multiple orthogonal methods\",\n      \"pmids\": [\"28560351\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"ARX directly represses Cdkn1c transcription; loss of Arx in cortical progenitors causes CDKN1C overexpression and reduced IPC proliferation; ARX was identified as a direct transcriptional regulator of CDKN1C by transcriptional profiling and direct binding studies.\",\n      \"method\": \"Conditional KO mouse, transcriptional profiling, ChIP, in situ hybridization, immunohistochemistry\",\n      \"journal\": \"Cerebral cortex\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO phenotype with ChIP validation of direct transcriptional regulation\",\n      \"pmids\": [\"23968833\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"The lncRNA Kcnq1ot1 promotes H3K27me3 accumulation at an intragenic MyoD-binding region of p57Kip2, suppressing its maternal allele expression during muscle differentiation; upon differentiation, MyoD binding to this region coincides with loss of EZH2/H3K27me3 and p57 de-repression.\",\n      \"method\": \"ChIP, RNA immunoprecipitation, Chromatin Oligo-affinity Precipitation, siRNA knockdown, allele-specific expression analysis\",\n      \"journal\": \"Epigenetics & chromatin\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP and RIP with allele-specific analysis, multiple orthogonal methods\",\n      \"pmids\": [\"30651140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"CSN6 (COP9 signalosome subunit 6) associates with p57(Kip2) and Skp2 (an SCF E3 ligase component), facilitating Skp2-mediated ubiquitination and proteasomal degradation of p57; CSN6 overexpression destabilizes p57 and promotes cell cycle progression.\",\n      \"method\": \"Co-IP, ubiquitination assay, CSN6 overexpression/knockdown, Western blot, cell proliferation assays\",\n      \"journal\": \"Cell cycle\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP, ubiquitination assay, loss-of-function rescue, single lab\",\n      \"pmids\": [\"23187808\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Akt phosphorylates p57(Kip2) at Ser282 or Thr310, causes cytoplasmic localization, accelerates protein turnover via ubiquitination, and thereby promotes HER2-mediated cell proliferation and tumorigenicity.\",\n      \"method\": \"Co-IP, phosphorylation mapping, ubiquitination assay, subcellular fractionation, cell proliferation/transformation assays\",\n      \"journal\": \"Cell cycle\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP plus phosphorylation site identification, ubiquitination assay, functional rescue\",\n      \"pmids\": [\"23421998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"FBXO22, a component of the SCF E3 ubiquitin ligase complex, physically interacts with p57Kip2 and mediates its ubiquitination and proteasomal degradation, promoting G1/S phase progression and cervical cancer cell proliferation.\",\n      \"method\": \"Co-IP, ubiquitination assay, protein half-life measurement, overexpression/knockdown, xenograft\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP plus direct ubiquitination assay with functional validation\",\n      \"pmids\": [\"36127346\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"RNF26 degrades p57(CDKN1C) to regulate cell cycle progression in bladder cancer; RNF26 expression is transcriptionally promoted by FOXM1 via the MuvB complex, forming a FOXM1/RNF26/p57 axis that modulates cell cycle and bladder cancer progression.\",\n      \"method\": \"Co-IP, Western blot, cell cycle analysis, gain- and loss-of-function experiments, ChIP\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP and ChIP with functional cell cycle readout, pathway defined\",\n      \"pmids\": [\"34650035\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Lsh, a SNF2 chromatin remodeling protein, directly associates with the 5' differentially methylated region (DMR) at the Cdkn1c promoter and controls CpG methylation at this locus to maintain paternal allele silencing; loss of Lsh causes reactivation of the silent paternal Cdkn1c allele.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), allele-specific expression analysis, bisulfite sequencing, Lsh-deficient embryos\",\n      \"journal\": \"Development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct ChIP evidence, allele-specific expression, bisulfite sequencing in KO model\",\n      \"pmids\": [\"15647320\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Targeted demethylation of the imprinting control region 2 (ICR2) using an ICR2-TET1 fusion protein represses p57 expression and promotes proliferation of human islet β cells while maintaining glucose-sensing functionality.\",\n      \"method\": \"TALE-TET1 epigenetic editing, Ki-67 staining, p57 Western blot, human islet transplantation in diabetic mice\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct epigenetic editing with functional consequence in human primary cells and in vivo transplant model\",\n      \"pmids\": [\"30352048\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"p57Kip2 is a molecular gatekeeper of the reserve stem cell state of gastric chief cells; p57 is constitutively expressed in homeostatic chief cells, rapidly diminishes after injury to allow robust proliferation, and its overexpression impairs injury response and locks cells in a reserve stem cell state.\",\n      \"method\": \"scRNA-seq, doxycycline-induced lineage tracing, in vivo constitutive p57 expression, corpus organoids, p57 overexpression\",\n      \"journal\": \"Cell stem cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal in vivo and in vitro genetic approaches with defined cellular phenotype\",\n      \"pmids\": [\"35523142\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"p57KIP2 expression is strongly induced by increased cell density in normal trophoblast stem cells and mediates contact inhibition; loss of p57KIP2 expression in androgenetic (CHM-derived) trophoblast stem cells causes resistance to contact inhibition and enhanced proliferation at confluence.\",\n      \"method\": \"Knockout and overexpression studies in human trophoblast stem cells, cell density assays\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO and OE with specific phenotypic readout in human cells\",\n      \"pmids\": [\"31792181\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"p57 downregulation in hepatocellular carcinoma cells increases CDK4/cyclin D1 and CDK2/cyclin E complex activities and accelerates invasion via controlling LIMK1 activity; stable p57 knockdown increases xenograft growth.\",\n      \"method\": \"Stable shRNA knockdown, CDK kinase immunocomplex assays, invasion assay, LIMK1 activity measurement, xenograft\",\n      \"journal\": \"Carcinogenesis\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with CDK kinase assays and defined pathway placement (LIMK1)\",\n      \"pmids\": [\"22002319\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"In Drosophila, the cyclin-dependent kinase inhibitor Dacapo (ortholog of p57KIP2) determines whether neural stem cells enter G0 or G2 quiescence; the dorsal patterning factor Msh binds directly to the Dap locus and induces Dap expression in dorsal NSCs, resulting in G0 arrest.\",\n      \"method\": \"ChIP, Drosophila genetics (msh and dap mutants), immunostaining, cell cycle staging\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus genetic epistasis in Drosophila ortholog system\",\n      \"pmids\": [\"30905769\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"The bHLH transcription factor E47 directly activates Cdkn1c expression by binding to a distal enhancer at the CDKN1C gene locus; E47 overexpression upregulates p57(KIP2) and disturbs layer-specific neurogenesis in vivo.\",\n      \"method\": \"ChIP-Seq, RNA-Seq, in utero electroporation, ChIP validation\",\n      \"journal\": \"Development\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP-Seq with in vivo functional validation\",\n      \"pmids\": [\"28939666\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"p73β, but not p53, activates transcription of CDKN1C (p57KIP2) and KvLQT1; p73 can regulate imprinted genes through mechanisms not shared by p53.\",\n      \"method\": \"Transient transfection reporter assays, Northern blot, comparison of p53 and p73 activity\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — reporter assay and expression analysis, single lab\",\n      \"pmids\": [\"11891335\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"SKP2 E3-ubiquitin ligase directly targets p57Kip2 for degradation in fusion-negative rhabdomyosarcoma, preventing myogenic differentiation; MYOD drives SKP2 overexpression via binding to an intronic enhancer, forming a MYOD-SKP2-p57 axis.\",\n      \"method\": \"Co-IP, ubiquitination assay, ChIP, RNA-seq, SKP2 knockdown/overexpression, in vivo xenograft\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct ubiquitination assay, ChIP, and in vivo validation with multiple orthogonal methods\",\n      \"pmids\": [\"38102140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"SMARCB1 restoration transcriptionally activates CDKN1C in rhabdoid tumor cells through increased histone H3 and H4 acetylation at the CDKN1C promoter; CDKN1C expression induces cell cycle arrest and knockdown of CDKN1C increases proliferation.\",\n      \"method\": \"Inducible SMARCB1 expression, ChIP for histone acetylation, siRNA knockdown, flow cytometry\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP evidence with functional KD/rescue, single lab\",\n      \"pmids\": [\"19221586\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"EZH2-mediated H3K27me3 at the CDKN1C promoter region is promoted by CDYL, which recruits EZH2 to silences CDKN1C transcription; EZH2 inhibition by GSK126 de-represses CDKN1C and decreases CDYL-induced chemoresistance in SCLC cells.\",\n      \"method\": \"ChIP-qPCR, Co-IP, GST pull-down, EMSA, bisulfite sequencing, gain- and loss-of-function experiments\",\n      \"journal\": \"Theranostics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — ChIP plus direct protein interaction assays, multiple methods\",\n      \"pmids\": [\"31367252\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Paternal allelic mutation at Kcnq1 reduces pancreatic β-cell mass by disrupting Kcnq1ot1 expression, which leads to increased Cdkn1c expression on the normally silenced maternal allele through altered histone modification at the Cdkn1c promoter in pancreatic islets.\",\n      \"method\": \"Kcnq1 KO mouse (allele-specific), ChIP for histone modifications, β-cell mass measurement, islet gene expression\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — allele-specific KO with ChIP mechanistic validation\",\n      \"pmids\": [\"26100882\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CDKN1C (p57KIP2) is a maternally-expressed, imprinted CDK inhibitor that restrains cell proliferation by binding and inhibiting cyclin/CDK complexes (especially CDK1 and CDK2); its stability is regulated by proteasomal degradation facilitated by multiple E3 ligases (SKP2, FBXO22, RNF26) and phosphorylation by Akt and p38-SAPK; it controls transcription by recruiting to E2F1-regulated promoters and inhibiting RNA Pol II CTD kinases (CDK7/CDK9); it interacts directly with MyoD to stabilize it during myogenesis; its subcellular localization (cytoplasmic vs. nuclear) is dynamically regulated and determines its growth-arrest function; it acts as a key regulator of stem cell quiescence, trophoblast giant cell differentiation (via CDK1 inhibition), oligodendrocyte precursor timing, erythroid cell fate (via replication fork speed control), and gastric chief cell reserve state; and its expression is epigenetically silenced by EZH2-mediated H3K27me3 (recruited by lncRNAs such as Kcnq1ot1 and BLACAT1) and by Lsh-dependent DNA methylation.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CDKN1C (p57KIP2) is a maternally expressed, imprinted cyclin-dependent kinase inhibitor that enforces cell-cycle exit, quiescence, and differentiation across diverse stem and progenitor cell populations. It directly binds and inhibits cyclin–CDK complexes—particularly CDK1 to trigger trophoblast giant cell endoreduplication and CDK2 upon p38-mediated T143 phosphorylation during stress responses—and additionally inhibits RNA Pol II CTD kinases CDK7 and CDK9 at E2F1-regulated promoters, thereby coupling cell-cycle arrest to transcriptional reprogramming [PMID:18981479, PMID:22569127, PMID:20106982]. Its protein levels are tightly controlled by proteasomal degradation mediated by the E3 ligases SCF-SKP2, SCF-FBXO22, and RNF26, with Akt phosphorylation promoting cytoplasmic relocalization and turnover, while IMAGe syndrome–causing gain-of-function mutations in the PCNA-binding domain impair this degradation and cause growth restriction [PMID:22634751, PMID:24098681, PMID:36127346, PMID:34650035, PMID:23421998]. Epigenetic silencing of CDKN1C is maintained by EZH2-catalyzed H3K27me3 directed by the lncRNA Kcnq1ot1 and by Lsh-dependent DNA methylation at the imprinting control region, while chromatin remodelers such as SMARCB1 and transcription factors including E47, Hes1, and ARX dynamically regulate its expression in tissue-specific contexts [PMID:19340297, PMID:30651140, PMID:15647320, PMID:19221586, PMID:16899237].\",\n  \"teleology\": [\n    {\n      \"year\": 1999,\n      \"claim\": \"Establishing that p57 is not merely redundant with p21 but cooperatively essential for cell-cycle exit during skeletal muscle differentiation resolved whether CIP/KIP family members have overlapping developmental roles.\",\n      \"evidence\": \"p57/p21 double-knockout mice failed to form myotubes, with persistent proliferation and apoptosis in myoblasts\",\n      \"pmids\": [\"9925645\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative individual contributions of p57 versus p21 to each step of myogenesis not separated\", \"Downstream CDK targets in myoblast exit not identified\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Discovery of a CDK-inhibition-independent function—direct physical stabilization of MyoD—revealed that p57 acts as a multifunctional scaffold linking cell-cycle arrest to myogenic transcription factor activity.\",\n      \"evidence\": \"Co-IP of endogenous proteins, domain mapping, and half-life measurements showed p57 N-terminal helix binds MyoD bHLH domain and increases MyoD stability\",\n      \"pmids\": [\"10764802\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether p57–MyoD interaction is required in vivo for myogenesis not shown genetically\", \"Mechanism by which p57 prevents MyoD degradation (e.g., which E3 ligase is blocked) not identified\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Genetic epistasis between p57 and PTHrP demonstrated that p57 is a critical downstream effector of growth plate signaling, placing it at the nexus of endocrine/paracrine regulation of chondrocyte proliferation.\",\n      \"evidence\": \"p57 deletion partially rescued PTHrP-null bone phenotype; PTH/PTHrP treatment reduced p57 mRNA and protein in chondrocytes\",\n      \"pmids\": [\"15124025\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Transcription factors mediating PTHrP-dependent p57 repression not identified\", \"Whether p57 inhibits CDK4/6 or CDK2 in chondrocytes not resolved\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identification of Lsh-dependent DNA methylation at the Cdkn1c differentially methylated region established a direct chromatin-remodeling mechanism for paternal allele silencing of this imprinted locus.\",\n      \"evidence\": \"ChIP, bisulfite sequencing, and allele-specific expression in Lsh-deficient embryos showed Lsh binds the Cdkn1c DMR and maintains CpG methylation\",\n      \"pmids\": [\"15647320\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How Lsh is recruited specifically to the Cdkn1c DMR not determined\", \"Relationship between Lsh-mediated methylation and Kcnq1ot1-mediated silencing not clarified\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Two concurrent findings—Hes1-mediated transcriptional repression in pancreatic progenitors and timer function in oligodendrocyte precursors—established p57 as a broadly used intracellular timer converting developmental signals into cell-cycle exit decisions.\",\n      \"evidence\": \"Hes1/p57 double-KO mouse epistasis and promoter analysis; clonal OPC culture with quantitative p57 accumulation measurements\",\n      \"pmids\": [\"16899237\", \"17553990\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of progressive p57 protein accumulation in OPCs not defined\", \"Whether Hes1 binds the p57 promoter directly in vivo confirmed only by promoter analysis\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"RNAi-mediated p57 knockdown caused cortical neuron migration defects independent of differentiation, revealing a CDK-inhibitor function in post-mitotic neuronal migration not previously appreciated.\",\n      \"evidence\": \"In utero electroporation of shRNA against p57 in mouse neocortex\",\n      \"pmids\": [\"17092932\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct CDK target mediating migration effect not identified\", \"Single knockdown approach without genetic KO confirmation\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Demonstrating that p57 specifically inhibits CDK1 to initiate endoreduplication in trophoblast stem cells defined the molecular selectivity of p57 for a particular CDK in a physiological context.\",\n      \"evidence\": \"CDK1-selective inhibitor phenocopied p57 in TS cells; p57 mutant TS cells failed to endoreduplicate; CDK kinase assays confirmed CDK1 targeting\",\n      \"pmids\": [\"18981479\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How p57 selectivity for CDK1 over CDK2 is achieved structurally not resolved\", \"Whether other CIP/KIP members can compensate for CDK1 inhibition in vivo\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Identification of EZH2-mediated H3K27me3 as a direct silencing mark at the CDKN1C locus linked Polycomb repression to p57 loss in cancer, establishing a targetable epigenetic axis.\",\n      \"evidence\": \"ChIP for H3K27me3 in breast cancer cells; pharmacological EZH2 and HDAC inhibition de-repressed CDKN1C\",\n      \"pmids\": [\"19340297\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism recruiting EZH2 specifically to CDKN1C in breast cancer cells not fully defined\", \"Whether H3K27me3 removal is sufficient to restore full p57 function not tested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Discovering that p57 is recruited to E2F1-regulated promoters and directly inhibits CDK7/CDK9 phosphorylation of the RNA Pol II CTD expanded p57's role from a pure cell-cycle inhibitor to a transcriptional co-regulator.\",\n      \"evidence\": \"ChIP showed p57 at E2F1 target promoters; in vitro kinase assays demonstrated p57 blocks CDK7/CDK9 CTD phosphorylation; Co-IP mapped E2F1–p57 interaction domains\",\n      \"pmids\": [\"20106982\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genome-wide scope of p57's transcriptional regulatory role not mapped\", \"Whether CDK7 vs CDK9 inhibition has distinct transcriptional consequences not distinguished\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Human genetic and functional studies established that gain-of-function PCNA-binding-domain mutations in CDKN1C cause IMAGe syndrome by dramatically increasing protein stability, linking the PCNA-dependent degradation pathway to a Mendelian growth restriction disorder.\",\n      \"evidence\": \"Exome sequencing of IMAGe families; Co-IP showing loss of PCNA binding; Drosophila expression assay; cycloheximide chase and proteasome inhibitor experiments\",\n      \"pmids\": [\"22634751\", \"24098681\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the E3 ligase that ubiquitinates p57 via PCNA interaction not determined at this stage\", \"Whether IMAGe mutations affect CDK-inhibitory activity in addition to stability not fully resolved\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identification of p38-SAPK phosphorylation at T143 as a signal that enhances p57–CDK2 binding revealed how stress signals are converted into cell-cycle delay through post-translational modification of a CKI.\",\n      \"evidence\": \"In vitro kinase assay, mutagenesis of T143, Co-IP showing enhanced CDK2 binding, genetic validation with p38/p57 inactivation\",\n      \"pmids\": [\"22569127\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether T143 phosphorylation also affects p57 interactions with CDK1 or other partners not tested\", \"Phosphatase responsible for reversing this modification not identified\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"CSN6-facilitated SKP2-mediated ubiquitination established the first defined E3 ligase pathway for proteasomal p57 turnover, with subsequent studies confirming SKP2, FBXO22, and RNF26 as parallel degradation routes.\",\n      \"evidence\": \"Co-IP and ubiquitination assays for CSN6/SKP2/p57; later confirmed by FBXO22 (2022) and RNF26 (2021) ubiquitination assays with functional cell-cycle readouts\",\n      \"pmids\": [\"23187808\", \"36127346\", \"34650035\", \"38102140\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Relative contributions of SKP2, FBXO22, and RNF26 in different tissues not compared\", \"Degron motifs recognized by each E3 ligase not precisely mapped beyond PCNA-binding domain\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Conditional knockout of p57 in adult hippocampal neural stem cells demonstrated that p57 is essential for maintaining quiescence and preventing stem cell exhaustion, generalizing p57's role as a quiescence gatekeeper beyond embryonic development.\",\n      \"evidence\": \"Conditional p57 KO in NSCs with BrdU/Ki67 tracing; initial neurogenesis burst followed by long-term NSC depletion\",\n      \"pmids\": [\"23481253\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether p57 enforces quiescence through CDK inhibition alone or also through transcriptional co-regulation in NSCs not resolved\", \"Upstream signals that maintain p57 expression in quiescent NSCs not fully defined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Akt-mediated phosphorylation at Ser282/Thr310 was shown to drive cytoplasmic relocalization and accelerated ubiquitin-dependent degradation of p57, revealing how growth factor signaling inactivates p57 to promote proliferation.\",\n      \"evidence\": \"Phosphorylation mapping, subcellular fractionation, ubiquitination assays in HER2-overexpressing cells\",\n      \"pmids\": [\"23421998\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether Akt phosphorylation feeds into SKP2 or a distinct E3 ligase pathway not determined\", \"In vivo relevance of Akt–p57 axis not validated genetically\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"DNA fiber assays revealed that p57 slows replication fork speed in erythroid progenitors and that its downregulation triggers a global fork speed increase coinciding with differentiation, establishing an unexpected S-phase-intrinsic role for a CKI in cell-fate decisions.\",\n      \"evidence\": \"DNA fiber assay in sorted erythroid progenitors from p57 KO and WT mice, flow cytometry for S-phase length\",\n      \"pmids\": [\"28560351\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism by which p57 slows replication forks (direct fork association vs. CDK inhibition at forks) not resolved\", \"Whether fork speed regulation is specific to erythroid cells or general\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Dynamic cytoplasmic-to-nuclear translocation of p57 in muscle stem cells demonstrated that subcellular localization is a regulated switch controlling the timing of growth arrest and differentiation onset.\",\n      \"evidence\": \"Immunofluorescence and subcellular fractionation in primary myoblasts; Cdkn1c KO showed differentiation defects\",\n      \"pmids\": [\"30284969\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinase or signal controlling nuclear import timing not identified\", \"Whether cytoplasmic p57 has active non-CDK functions in myoblasts not explored\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"The lncRNA Kcnq1ot1 was shown to recruit EZH2 to deposit H3K27me3 at an intragenic MyoD-binding region of p57, directly linking imprinting-associated lncRNA to the epigenetic silencing mechanism and its reversal during myogenic differentiation.\",\n      \"evidence\": \"ChIP, RNA immunoprecipitation, and chromatin oligo-affinity precipitation with allele-specific analysis in myoblasts\",\n      \"pmids\": [\"30651140\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether Kcnq1ot1 uses the same EZH2-recruitment mechanism in non-muscle tissues not tested\", \"Structural basis for Kcnq1ot1–EZH2 interaction not characterized\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identification of p57 as a molecular gatekeeper of the reserve stem cell state in gastric chief cells extended its quiescence-maintenance role to adult tissue homeostasis and injury response, showing that rapid p57 loss is required for damage-induced regeneration.\",\n      \"evidence\": \"scRNA-seq, lineage tracing, in vivo constitutive p57 expression, and corpus organoid experiments\",\n      \"pmids\": [\"35523142\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Upstream signal that triggers rapid p57 downregulation upon gastric injury not identified\", \"Whether p57 loss alone is sufficient for chief cell dedifferentiation or requires cooperating signals\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include: which E3 ligase mediates PCNA-dependent p57 degradation in the IMAGe syndrome context; how p57 mechanistically slows replication forks; what signals control the cytoplasmic-to-nuclear translocation switch; and whether p57's transcriptional co-regulatory function via CDK7/CDK9 inhibition is genome-wide or restricted to specific promoter classes.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"PCNA-dependent E3 ligase identity unresolved\", \"Structural basis for p57 at replication forks unknown\", \"Nuclear import signal and its regulatory kinase/phosphatase not mapped\", \"Genome-wide ChIP for p57 occupancy at promoters not performed\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 6, 8, 11, 12, 15, 24, 25, 26]},\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [1, 6, 8, 26]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [8, 14]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [14, 19]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [0, 1, 5, 6, 15, 18, 19, 20, 21, 25, 26]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 1, 9, 10, 11, 12, 13, 14, 24]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [8, 17, 22, 31, 32, 33]},\n      {\"term_id\": \"R-HSA-4839726\", \"supporting_discovery_ids\": [7, 17, 22, 32, 33]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [4, 18, 19, 20, 21, 30]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"CDK1\",\n      \"CDK2\",\n      \"MYOD1\",\n      \"E2F1\",\n      \"SKP2\",\n      \"FBXO22\",\n      \"EZH2\",\n      \"CDK7\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}